Ecosyste.ms: Papers
An open API service providing mapping between scientific papers and software projects that are mentioned in them.
All mentions data is based on the CZI Software Mentions dataset.
Papers: 10.1186/s12885-019-5507-6
https://doi.org/10.1186/s12885-019-5507-6
Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials
Cited by: 7
Author(s): Martin Connock, Xavier Armoiry, Alexander Tsertsvadze, G. J. Melendez‐Torres, Pamela Royle, Lazaros Andronis, Aileen Clarke
Published: over 5 years ago